Genetic sequencing instruments key to pandemic battle : Indigenus

Indian-born British chemist Shankar Balasubramanian lately received the Millennium Expertise Prize, instituted by the Expertise Academy Finland, for improvement of revolutionary DNA sequencing methods. Vanita Srivastava caught up with him to know the award successful genetic sequencing work that has extensively impacted the fields of genomics, drugs and biology.

[Shankar Balasubramanian is a Herchel Smith Professor of Medicinal Chemistry in the Department of Chemistry at the University of Cambridge, a Senior Group Leader at the Cancer Research UK Cambridge Institute and a Fellow of Trinity College, Cambridge. He won the one million euro prize jointly with David Klenerman.]

Shankar Balasubramanian

College of Cambridge

Q. Inform us about your genome sequencing expertise and the way it has impacted the course of the COVID-19 pandemic.

A. Prof David Klenerman and I are co-inventors of Solexa-Illumina Subsequent Technology DNA Sequencing (NGS). The expertise was totally developed at Solexa into an built-in, business system, then additional improved by the workforce in Illumina. This expertise has enabled quick, correct, low-cost and large-scale genome sequencing, which is the method of figuring out the whole DNA sequence of an organism’s make-up.

Through the pandemic, NGS has been offering an efficient solution to examine SARS-CoV-2’s genetic make-up and assist us monitor the viral mutations, which continues to be an awesome international concern. This work has additionally helped the creation of a number of vaccines now being administered worldwide and is essential to the creation of recent vaccines towards new harmful viral strains.

Q. India is now a hotspot of coronavirus mutants. How can this expertise assist deal with issues regarding this?

A. By finding out and understanding the genetic make-up of the brand new mutant utilizing our expertise, we are able to determine its potential as a brand new menace by figuring out the way it differs from the opposite variants. Additional, I hope that our expertise will be helpful in sequencing the genomes of people that have had COVID and attempting to get an understanding of why some persons are severely affected by the illness and others are asymptomatic. This strategy might determine threat components in particular individuals that will even be relevant to different viruses in years to come back.

Q. What different potential use does this expertise have?

A. The expertise has an enormous transformative affect within the fields of genomics, drugs and biology. It’s being utilized extensively within the primary analysis of residing techniques, as DNA and RNA are basic to cells and organisms. Facets of residing techniques embrace genetics, the expression of genes, the construction of DNA within the nucleus and variations between cells, to call however just a few.

The expertise is starting to be utilized in drugs, notably within the areas of most cancers and uncommon illnesses. The purposes in drugs will develop as we sequence extra human genomes permitting the concept of personalised drugs the place illnesses are extra optimally handled by understanding the person and the medicine which can be used are designed to appropriate the molecular pathway that has gone in a particular particular person. It should even be utilized in agriculture to breed species with desired properties.

Over the previous few years, there have been great advances in most cancers, each with remedy and in addition detection and prognosis. Over the approaching a long time, the purpose is to make use of this expertise to assist make some cancers turn into manageable illnesses as a result of they’re detected sufficiently early and it’s clear what needs to be accomplished. This might additionally hopefully be prolonged to different advanced illnesses similar to coronary heart illness and Alzheimer’s illness.

Q. What are the challenges to personalised genomic drugs?

A. Growing an efficient and environment friendly infrastructure for sequencing sufferers on a big scale and utilizing their genetic profile to assist make the choices in regard to the prevention, prognosis, and therapy of their illness is at the moment the most important problem.

Related Articles

Leave a Reply

Your email address will not be published.

Back to top button